144Filing Date: Aug 10, 2026

Regeneron (REGN)

Insider Proposed Sale Notice

View SEC Filing
ACC: 0001969223-26-000871

Sale Plan

Zoghbi Huda Y
Director·Regeneron
Proposed
CommonNASDAQ
Shares800
Est. DateAug 10
Market Value$640.0K
BrokerUBS Financial Services, Inc.
AcquisitionExercise of stock options · Issuer
Acquired DateAug 10, 2026
Amount Acquired800
10b5-1 Plan Adoption11/20/2025
% Outstanding0.0008%
10b5-1
Exercise / Payment Details
Paid: Aug 10, 2026Method: Cash
No sales in the past 3 months
Signature & Compliance expand_more
Notice DateAug 10, 2026
10b5-1 Plan Adoption11/20/2025
Signature /s/ UBS Financial Services Inc, as attorney-in-fact for Huda Zoghbi
Issuer Info expand_more
CompanyREGENERON PHARMACEUTICALS, INC.
CIK0000872589
SEC File No.000-19034
Phone9148477000
Address777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY 10591

keid analysis is for reference only and does not constitute investment advice.